Page last updated: 2024-08-25

clarithromycin and colchicine

clarithromycin has been researched along with colchicine in 28 studies

Research

Studies (28)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (35.71)	29.6817
2010's	16 (57.14)	24.3611
2020's	2 (7.14)	2.80

Authors

Authors	Studies
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA	1
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, X; Lin, X; Skolnik, S; Wang, J	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bharate, SS; Vishwakarma, RA	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dogukan, A; Güven, M; Oymak, FS; Taskapan, H; Tokgoz, B; Utas, C	1
Blanche, P; Chauvelot-Moachon, L; Kélaïdi, C; Nazal, EM; Pajot, O; Rollot, F	1
Cheng, VC; Cheung, BM; Hung, IF; Lau, SK; Tang, BS; To, KW; Woo, PC; Wu, AK; Yeung, CK; Yuen, KY	1
Cheng, VC; Ho, PL; Yuen, KY	1
de Sévaux, R; Huussen, J; Ter Laak, H; van der Velden, W	1
McKinnell, J; Tayek, JA	1
Aks, SE; Bentur, Y; Dubnov-Raz, G; Finkelstein, Y; Hutson, JR; Juurlink, DN; Koren, G; Nguyen, P; Pollak, U	1
Goh, IX; How, CH; Tavintharan, S	1
Mustafa, G; Necati, B	1
Franklin, JM; Kesselheim, AS; Kim, SC; Seeger, JD; Solomon, DH	1
Cohen, O; Gorshtein, A; Hershko, AY; Levy, Y; Locketz, G	1
Ben Zvi, I; Haj Yahia, S; Livneh, A	1
Boyce, RD; Gephart, S; Hansten, PD; Horn, JR; Malone, DC; Romero, A; Subbian, V; Villa Zapata, L	1
Gomez-Lumbreras, A; Malone, DC; Tan, MS; Villa-Zapata, L	1

Reviews

3 review(s) available for clarithromycin and colchicine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Colchicine poisoning: the dark side of an ancient drug. Clinical toxicology (Philadelphia, Pa.), 2010, Volume: 48, Issue:5 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Charcoal; Clarithromycin; Clinical Trials as Topic; Colchicine; Colony-Stimulating Factors; Drug Interactions; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Familial Mediterranean Fever; Female; Granulocyte Colony-Stimulating Factor; Humans; Male	2010
Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. Rheumatology international, 2015, Volume: 35, Issue:11 Topics: Adult; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Clarithromycin; Colchicine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Factors; Male; Middle Aged; Polypharmacy; Rhabdomyolysis	2015

Other Studies

25 other study(ies) available for clarithromycin and colchicine

Article	Year
Rational use of in vitro P-glycoprotein assays in drug discovery. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:2 Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera	2001
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism. Bioorganic & medicinal chemistry letters, 2005, Sep-15, Volume: 15, Issue:18 Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride	2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery. Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7 Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics	2015
Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration. Clinical nephrology, 2001, Volume: 55, Issue:2 Topics: Aged; Amyloidosis; Anti-Bacterial Agents; Clarithromycin; Colchicine; Drug Interactions; Fatal Outcome; Gout Suppressants; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory	2001
Severe colchicine-macrolide interactions. Prescrire international, 2003, Volume: 12, Issue:63 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colchicine; Cytochrome P-450 Enzyme System; Drug Interactions; Glycoproteins; Humans; Josamycin; Male; Omeprazole	2003
Acute colchicine intoxication during clarithromycin administration. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Gastritis; Gout Suppressants; Helicobacter pylori; Humans; Male; Omeprazole	2004
Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-01, Volume: 41, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Colchicine; Contraindications; Drug Interactions; Female; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Retrospective Studies; Risk Factors; Survival Rate	2005
Two probable cases of serious drug interaction between clarithromycin and colchicine. Southern medical journal, 2005, Volume: 98, Issue:8 Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Colchicine; Drug Synergism; Fatal Outcome; Female; Gout Suppressants; Humans; Male; Middle Aged	2005
Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. The Netherlands journal of medicine, 2008, Volume: 66, Issue:5 Topics: Aged; Anti-Bacterial Agents; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Colchicine; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Kidney Failure, Chronic; Male; Neuromuscular Diseases; Risk Factors; Simvastatin; Tubulin Modulators	2008
Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:6 Topics: Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Colchicine; Community-Acquired Infections; Doxycycline; Drug Interactions; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pneumonia, Bacterial; Rhabdomyolysis; Treatment Outcome	2009
Cytochrome P450 drug interactions with statin therapy. Singapore medical journal, 2013, Volume: 54, Issue:3 Topics: Aged; Clarithromycin; Colchicine; Creatine Kinase; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscle Weakness; Muscles; Myalgia; Patient Safety	2013
Clarithromycin-associated rhabdomyolysis in an infant. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:8 Topics: Anti-Bacterial Agents; Clarithromycin; Colchicine; Gout Suppressants; Humans; Male; Rhabdomyolysis	2014
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population. Journal of general internal medicine, 2015, Volume: 30, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Colchicine; Drug Approval; Drug Costs; Drug Interactions; Drug Prescriptions; Drug Utilization; Economic Competition; Familial Mediterranean Fever; Female; Gout; Gout Suppressants; Health Care Costs; Humans; Insurance, Health; Male; Middle Aged; Retrospective Studies; United States; United States Food and Drug Administration	2015
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. Rheumatology international, 2018, Volume: 38, Issue:1 Topics: Abdominal Pain; Adult; Aged; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Female; Helicobacter Infections; Humans; Middle Aged; Retrospective Studies; Rhabdomyolysis	2018
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. Drug safety, 2020, Volume: 43, Issue:7 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Colchicine; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Gout Suppressants; Humans; Kidney Diseases; Male; Pharmacogenetics; United States; United States Food and Drug Administration; Young Adult	2020
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure. Rheumatology international, 2022, Volume: 42, Issue:12 Topics: Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Colchicine; Erythromycin; Humans; Macrolides; Male	2022